Dear Colleague,

I am pleased to invite you to our fourth annual FierceBiotech Executive Summit: London taking place on October 30, 2018 at the Royal Society of Medicine. At this year's event, we will speak with key leaders to discuss the infrastructures of biomedical science across the U.K. and the challenges and opportunities to boosting life sciences amid a time of major change as the U.K. approaches a future outside of the European Union.

In addition to networking opportunities, the Executive Summit will feature multiple panel discussions and a fireside chat. Here's a preview of the 2018 program:

Panel One / Challenges and Opportunities for Life Science Post-Brexit

• Dr. Chris Doherty // Managing Director // Alderley Park
  
• Matthew Durdy (High Honors), MA (Oxon.) FCSI // Chief Business Officer of the Cell and Gene Therapy // Catapult
  
• Dr. Peter Jackson // Executive Director // The AMR Centre
  

• Steve Bates // CEO // BioIndustry Association
  
• Ben Adams (Moderator) // Editor // FierceBiotech
  

• Dr. Munna Choudhury // Management Consultant // Accenture

Stay tuned for additonal speaker announcements! Register now and reserve your spot at the Summit - seats are limited.

Best regards,
Rebecca Willumson
Publisher
FierceBiotech & FiercePharma

- If you have any questions about this event, please contact asecondini@questex.com.